Kósa, D.; Pető, Á.; Fenyvesi, F.; Váradi, J.; Vecsernyés, M.; Budai, I.; Németh, J.; Fehér, P.; Bácskay, I.; Ujhelyi, Z.
Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems. Pharmaceutics 2022, 14, 9.
https://doi.org/10.3390/pharmaceutics14010009
AMA Style
Kósa D, Pető Á, Fenyvesi F, Váradi J, Vecsernyés M, Budai I, Németh J, Fehér P, Bácskay I, Ujhelyi Z.
Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems. Pharmaceutics. 2022; 14(1):9.
https://doi.org/10.3390/pharmaceutics14010009
Chicago/Turabian Style
Kósa, Dóra, Ágota Pető, Ferenc Fenyvesi, Judit Váradi, Miklós Vecsernyés, István Budai, József Németh, Pálma Fehér, Ildikó Bácskay, and Zoltán Ujhelyi.
2022. "Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems" Pharmaceutics 14, no. 1: 9.
https://doi.org/10.3390/pharmaceutics14010009
APA Style
Kósa, D., Pető, Á., Fenyvesi, F., Váradi, J., Vecsernyés, M., Budai, I., Németh, J., Fehér, P., Bácskay, I., & Ujhelyi, Z.
(2022). Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems. Pharmaceutics, 14(1), 9.
https://doi.org/10.3390/pharmaceutics14010009